Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1982-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.21.6.1016PMID 6956247PMCID PMC182066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp

  1981cited by this paper
• In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime

  1981cited by this paper
• N-formimidoyl thienamycin (MK0787): in vitro study

  1981cited by this paper
• Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics

  1980cited by this paper
• In vitro activity of N-formimidoyl thienamycin (MK0787)

  1980cited by this paper
• MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

  1980cited by this paper
• In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin

  1980cited by this paper

• and apalcillin against anaerobic bacteria. Comparative in vitro activities of cefpiramide

  2013cites this paper
• Cephalosporins in Surgery

  2012cites this paper
• Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis

  2003cites this paper
• Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species‐specific antibody

  2002cites this paper
• Mucosal microflora from patients with ulcerative colitis ( UC ) and toxicity of mucosal bacteria to Vero cell

  2002cites this paper
• Roles of mucosal bacteria and succinic acid in colitis caused by dextran sulfate sodium in mice.

  2000cites this paper
• The newer cephalosporins. Aztreonam and imipenem.

  1995cites this paper
• Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.

  1993cites this paper
• Human pancreatic tissue concentration of bactericidal antibiotics.

  1992cites this paper
• The use of antibiotics in general surgery.

  1991cites this paper
• [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].

  1989cites this paper
• Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.

  1989cites this paper
• Belgian collaborative study of the in-vitro susceptibility of the Bacteroides fragilis group

  1988cites this paper
• Current Trends in the Management of Upper Respiratory Tract Bacterial Infections

  1988cites this paper
• Antimicrobial resistance in oral and colonic bacteroides.

  1988cites this paper
• Cefotetan: a review of the microbiologic properties and antimicrobial spectrum.

  1988cites this paper
• A comparison of cefotaxime versus cefamandole in prophylaxis for surgical treatment of the biliary tract.

  1987cites this paper
• In vitro activity of imipenem against gram-positive anaerobic bacteria.

  1987cites this paper
• Cefmenoxime

  1987cites this paper
• Comparative serum bactericidal activity against test anaerobes in volunteers receiving imipenem, clindamycin, latamoxef and metronidazole.

  1987cites this paper
• The cephalosporins.

  1987cites this paper
• Cephalosporins in surgery. Prophylaxis and therapy.

  1987cites this paper
• Multicenter in vitro study of the susceptibility of the Bacteroides fragilis group in Belgium.

  1986cites this paper
• Resistance factors in anaerobic bacteria.

  1986cites this paper
• Anaerobic meningitis in children

  1986cites this paper
• Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals

  1986cites this paper
• Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray

  1986cites this paper
• Ecological Impacts of Antibacterial Agents: Stockholm, March 7–8, 1986

  1986cites this paper
• In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria

  1985cites this paper
• Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.

  1985cites this paper
• Imipenem: first of a new class of beta-lactam antibiotics.

  1985cites this paper
• Antibacterial activity of imipenem: the first thienamycin antibiotic.

  1985cites this paper
• In vitro activity of imipenem against anaerobic bacteria.

  1985cites this paper
• [Comparative sensitivity of 207 strains of strict anaerobic bacteria to piperacillin and 4 other antibiotics].

  1985cites this paper
• Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.

  1985cites this paper
• In-vitro activity of Sch 34343 against anaerobic bacteria.

  1985cites this paper
• Imipenem/cilastatin in the treatment of obstetric and gynecologic infections: a review of worldwide experience.

  1985cites this paper
• Impact of imipenem/cilastatin therapy on normal fecal flora.

  1985cites this paper
• Ceftizoxime

  1985cites this paper
• Imipenem/Cilastatin sodium (MK-0787/MK-0791) の嫌気性菌に対する抗菌力

  1985cites this paper
• 新Carbapenem系誘導体Imipenem (MK-0787) の細菌学的評価

  1985cites this paper
• InVitro Activity ofSch34343andCefbuperazone Against

  1985cites this paper
• Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group

  1984cites this paper
• NOTES Susceptibility ofAnaerobic Bacteria fromSeveral FrenchHospitals toThreeMajorAntibiotics

  1984cites this paper
• Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group.

  1984cites this paper
• Cefmenoxime Therapy ofSerious Bacterial Infections

  1984cites this paper
• Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria

  1984cites this paper
• Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics

  1984cites this paper
• Increasing incidence of clinical isolates of Bacteroides fragilis resistant to clindamycin.

  1984cites this paper
• In vitro activity of imipenem — A review

  1984cites this paper
• [In vitro sensitivity of strict anaerobic Gram-negative bacilli to thienamycin NF and various cephalosporins].

  1984cites this paper
• Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.

  1984cites this paper
• Comparative InVitro Activities ofCefpiramide andApalcillin Against Anaerobic Bacteria

  1984cites this paper
• Effect ofClavulanic AcidontheActivities ofTenP-Lactam Agents Against MembersoftheBacteroides fragilis Group

  1984cites this paper
• [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].

  1984cites this paper
• Susceptibility of intestinal anaerobes to new beta-lactam antibiotics.

  1984cites this paper
• Cefmenoxime therapy of serious bacterial infections

  1984cites this paper
• Etude de la sensibilité antibiotique des anaérobies stricts

  1983cites this paper
• Isolation of Clostridium pseudotetanicum from a patient with gas gangrene

  1983cites this paper
• Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat.

  1983cites this paper
• Susceptibility of anaerobic bacteria to imipenem.

  1983cites this paper
• Susceptibility studies in the Bacteroides fragilis group resistant to clindamycin.

  1983cites this paper
• [Antibiotic prevention in gynecology. Concentrations of ceftizoxime in the serum, myometrium, endometrium and fallopian tubes].

  1983cites this paper
• Comparative study of imipenem in severe infections.

  1983cites this paper
• Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.

  1983cites this paper